Dr. Matthew Hill
π€ SpeakerAppearances Over Time
Podcast Appearances
It's a great study of the placebo effect.
It's a great study of the placebo effect.
Yeah. So health harms, I mean... Someone smoking, obviously there's risks for lung damage. I would say the evidence for things like lung cancer certainly don't hold the way they do with cigarette smoke.
Yeah. So health harms, I mean... Someone smoking, obviously there's risks for lung damage. I would say the evidence for things like lung cancer certainly don't hold the way they do with cigarette smoke.
Yeah. So health harms, I mean... Someone smoking, obviously there's risks for lung damage. I would say the evidence for things like lung cancer certainly don't hold the way they do with cigarette smoke.
I don't think you could make the argument about fewer carcinogens per se. I think... Probably it relates more to the frequency. I mean, Donald Tashkin, who's in California here, I think he was at UCLA. I'm not 100% sure, but I know he was in California.
I don't think you could make the argument about fewer carcinogens per se. I think... Probably it relates more to the frequency. I mean, Donald Tashkin, who's in California here, I think he was at UCLA. I'm not 100% sure, but I know he was in California.
I don't think you could make the argument about fewer carcinogens per se. I think... Probably it relates more to the frequency. I mean, Donald Tashkin, who's in California here, I think he was at UCLA. I'm not 100% sure, but I know he was in California.
He did like very long-term studies tracking cannabis smokers and basically did not find associations with lung cancer the way that you do with cigarette smoking. Why that's the case, I don't think anyone has. Like people have theories. Some suggest because a lot of this in vitro animal work with really high dosing suggests it could have anti-proliferative effects for tumors.
He did like very long-term studies tracking cannabis smokers and basically did not find associations with lung cancer the way that you do with cigarette smoking. Why that's the case, I don't think anyone has. Like people have theories. Some suggest because a lot of this in vitro animal work with really high dosing suggests it could have anti-proliferative effects for tumors.
He did like very long-term studies tracking cannabis smokers and basically did not find associations with lung cancer the way that you do with cigarette smoking. Why that's the case, I don't think anyone has. Like people have theories. Some suggest because a lot of this in vitro animal work with really high dosing suggests it could have anti-proliferative effects for tumors.
Whether that's real or not, I don't know. But like... I think more likely it's because most people who smoke cigarettes, at least that were, you know, the relationship with lung cancer were people who were smoking regularly throughout the day. And it's very rare someone smokes cannabis at that frequency. Maybe if they isolated that population, they would see relationships with lung cancer.
Whether that's real or not, I don't know. But like... I think more likely it's because most people who smoke cigarettes, at least that were, you know, the relationship with lung cancer were people who were smoking regularly throughout the day. And it's very rare someone smokes cannabis at that frequency. Maybe if they isolated that population, they would see relationships with lung cancer.
Whether that's real or not, I don't know. But like... I think more likely it's because most people who smoke cigarettes, at least that were, you know, the relationship with lung cancer were people who were smoking regularly throughout the day. And it's very rare someone smokes cannabis at that frequency. Maybe if they isolated that population, they would see relationships with lung cancer.
I just don't think it's been borne out by the data the same way. Certainly lung damage, emphysema, things like that are on par. If you have any combustion product, you're going to have damage there. There's no question about that. So, again, harm reduction perspective would be, you know, oral routes of administration bypass lung damage. They come with their own issues with dosing and whatnot.
I just don't think it's been borne out by the data the same way. Certainly lung damage, emphysema, things like that are on par. If you have any combustion product, you're going to have damage there. There's no question about that. So, again, harm reduction perspective would be, you know, oral routes of administration bypass lung damage. They come with their own issues with dosing and whatnot.
I just don't think it's been borne out by the data the same way. Certainly lung damage, emphysema, things like that are on par. If you have any combustion product, you're going to have damage there. There's no question about that. So, again, harm reduction perspective would be, you know, oral routes of administration bypass lung damage. They come with their own issues with dosing and whatnot.
But if you're talking about physical harms, that's one thing to avoid that you could bypass that aspect of it with. There is some, I don't think we are at a point where we can say the state of it. There is something with cardiovascular function and cannabis that relates to higher frequency of strokes perhaps, or cardiac events in some capacity. The data is not entirely clear in this sense yet.
But if you're talking about physical harms, that's one thing to avoid that you could bypass that aspect of it with. There is some, I don't think we are at a point where we can say the state of it. There is something with cardiovascular function and cannabis that relates to higher frequency of strokes perhaps, or cardiac events in some capacity. The data is not entirely clear in this sense yet.
But if you're talking about physical harms, that's one thing to avoid that you could bypass that aspect of it with. There is some, I don't think we are at a point where we can say the state of it. There is something with cardiovascular function and cannabis that relates to higher frequency of strokes perhaps, or cardiac events in some capacity. The data is not entirely clear in this sense yet.